Senomyx (SNMX)
Senomyx Free Cash Flow TTM: -15.21M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SNMX Free Cash Flow TTM Rankings
| Overall | 17th percentile | 3420 of 4142 |
| Sector | 34th percentile | 309 of 474 in Basic Materials |
| Industry | 7th percentile | 48 of 52 in Specialty Chemicals |
SNMX Free Cash Flow TTM Range, Past 5 Years
| Minimum | -28.79M | Sep 2008 |
| Maximum | 23.02M | Sep 2010 |
| Average | -9.142M |
About Free Cash Flow (TTM)
Free Cash Flow (TTM) is the sum of the last four quarters of Free Cash Flows.
For details about how YCharts calculates its quarterly Free Cash Flow numbers, click "Learn More" below.
Learn More
You may also be interested in these SNMX related companies
SNMX News
Senomyx's CEO Presents at Citi 2012 Global Consumer Conference - Conference Call Transcript
May 24, 11:02AM Seeking Alpha
May 24, 11:02AM Seeking Alpha
SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2012 GLOBAL CONSUMER CONFERENCE
May 17, 8:30AM Business Wire
May 17, 8:30AM Business Wire
Senomyx's CEO Presents at Deutsche Bank 37th Annual Healthcare Conference (Transcript)
May 09, 8:56PM Seeking Alpha
May 09, 8:56PM Seeking Alpha
Listen to $SNMX Senomyx, Inc. at Deutsche Bank Health Care Conference - live at 04:10 PM, ondemand after - http://stks.co/3jEs
about 24 days ago by earningscast
about 24 days ago by earningscast
Listen to $SNMX Q1 2012 earnings call - live at 11:00 AM, ondemand after - http://stks.co/3eNj
about 30 days ago by earningscast
about 30 days ago by earningscast
Senomyx Announces Corporate Update and First Quarter 2012 Financial Results
May 03, 8:30AM Marketwire
May 03, 8:30AM Marketwire
Senomyx to Webcast Corporate Presentation at the Deutsche Bank 37th Annual Health Care Conference
May 01, 8:30AM Marketwire
May 01, 8:30AM Marketwire
Senomyx, Inc. First Quarter Earnings Conference Call Scheduled for May 3, 2012
Apr 26, 8:30AM Business Wire
Apr 26, 8:30AM Business Wire
Senomyx to Webcast Corporate Presentation at the 11th Annual Needham Healthcare Conference
Mar 27, 8:30AM Marketwire
Mar 27, 8:30AM Marketwire
Senomyx, Inc. [SNMX] CEO & Chairman to Ring The NASDAQ Stock Market Opening Bell
Mar 07, 10:33AM GlobeNewswire
Mar 07, 10:33AM GlobeNewswire
Senomyx to Webcast Corporate Presentation at the ROTH 24th Annual OC Growth Stock Conference
Mar 07, 8:30AM Marketwire
Mar 07, 8:30AM Marketwire
Listen to $SNMX Q4 2011 earnings call - live at 11:00 AM, ondemand after - http://stks.co/2dGb
about 93 days ago by earningscast
about 93 days ago by earningscast
Senomyx Announces Corporate Update and Fourth Quarter and Full Year 2011 Financial Results
Mar 01, 8:30AM Marketwire
Mar 01, 8:30AM Marketwire
Senomyx to Webcast Corporate Presentation at the 14th Annual Needham Growth Conference
Jan 04, 8:30AM Marketwire
Jan 04, 8:30AM Marketwire
SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2011 FINANCIAL RESULTS
Oct 27, 8:30AM Business Wire
Oct 27, 8:30AM Business Wire
SENOMYX, INC. THIRD QUARTER EARNINGS CONFERENCE CALL SCHEDULED FOR OCTOBER 27, 2011
Oct 21, 8:30AM Business Wire
Oct 21, 8:30AM Business Wire
$SNMX "competitor" $RPBC on verge of insolvency. Have stevia based sweet enhancer (Reb-C vs Reb-A) licensed to IFF: http://stks.co/4ti
about 273 days ago by BioDueDiligence
about 273 days ago by BioDueDiligence
Posted last night: $INFI 2q2011 CC notes: http://stks.co/4Xx Last two 2q11 posts for $SNMX and $AIS coming today!
about 274 days ago by BioDueDiligence
about 274 days ago by BioDueDiligence
Notes from $SNMX 2q2011 call: http://goo.gl/8hUJ5 Sucralose/Spelnda enhancer is on shelves. Selected new beverage sucrose enhancer w/ $PEP
about 279 days ago by BioDueDiligence
about 279 days ago by BioDueDiligence
SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE MIDWEST IDEAS INVESTOR CONFERENCE
Aug 24, 8:30AM Business Wire
Aug 24, 8:30AM Business Wire
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2011 FINANCIAL RESULTS
Aug 05, 8:30AM Business Wire
Aug 05, 8:30AM Business Wire
SENOMYX, INC. SECOND QUARTER EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 5, 2011
Aug 01, 8:30AM Business Wire
Aug 01, 8:30AM Business Wire
$SNMX $5.93 BERGER DAVID B (V.P. General Counsel & Sec.) S 3,082 @ $6.12 amnt $18,853 proc'd $586 7/7/2011 w/trading plan 11/23/2010
about 326 days ago by canarionyc
about 326 days ago by canarionyc
Sorry to post in retrospect: Raised just a bit of cash by selling $SNMX @ 5.78 Friday and $MNTA @ 20.55 today (first sale ever of this one)
about 332 days ago by BioDueDiligence
about 332 days ago by BioDueDiligence
@newyorker piece re future vision @ $PEP. Interesting: they have internal $SNMX like efforts but still signed big deal http://stk.ly/jVsi1z
about 352 days ago by BioDueDiligence
about 352 days ago by BioDueDiligence
Note that if new $PEP product contains a $SNMX sucrose or fructose enhancer, they have been coy (misleading) about status of those molecules
about 352 days ago by BioDueDiligence
about 352 days ago by BioDueDiligence
$PEP market testing 60% reduced sugar Pepsi NEXT. May be part of reason for recent $SNMX decline http://stk.ly/jreF5A
about 352 days ago by BioDueDiligence
about 352 days ago by BioDueDiligence
@mrland_news Can you share any details on what you're hearing on $SNMX or source?
about 352 days ago by BioDueDiligence
about 352 days ago by BioDueDiligence
Once again didn't quite pull the trigger on $MYRX $SNTA $SNMX $INFI being very greedy right now on these pullbacks
about 358 days ago by BioDueDiligence
about 358 days ago by BioDueDiligence
kicking myself for passing on selling some $SNMX at 6.40 the other day. But really really worth a look here at EV <$150m
about 359 days ago by BioDueDiligence
about 359 days ago by BioDueDiligence
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SNMX | 2.07 | -0.26 | -11.16% | 92.66M |
| SNI | 53.43 | -1.34 | -2.45% | 6.692B |
| SNHY | 22.38 | -0.95 | -4.07% | 601.21M |
| SNH | 20.20 | -0.45 | -2.18% | 3.359B |
| SNFCA | 2.06 | -0.26 | -11.21% | 45.87M |
| SNE | 12.65 | -0.59 | -4.46% | 13.29B |
| SNDK | 31.22 | -1.48 | -4.53% | 7.926B |
| SNDA | 41.28 | +0.00 | +0.00% | |
| SNCR | 17.34 | -0.57 | -3.18% | 689.89M |
| SLW | 26.63 | +1.15 | +4.51% | 9.008B |